tiprankstipranks
Trending News
More News >
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market

Acrivon Therapeutics, Inc. (ACRV) Income Statement

Compare
717 Followers

Acrivon Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Acrivon Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Acrivon Therapeutics, Inc.'s net income was $-18.23M. See Acrivon Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.01M$ -536.00K$ 0.00$ 0.00$ -13.00K
Operating Expenses
$ 88.19M$ 66.70M$ 32.66M$ 16.18M$ 3.17M
Depreciation and Amortization
$ 1.01M$ 536.00K$ 364.00K$ 37.00K$ 13.00K
EBITDA
$ -79.55M$ -59.85M$ -32.29M$ -16.15M$ -5.29M
Operating Income
$ -89.20M$ -67.24M$ -32.66M$ -16.18M$ -3.17M
Other Income/Expenses
$ 8.64M$ 6.85M$ 1.49M$ -59.00K$ -2.14M
Pretax Income
$ -80.56M$ -60.39M$ -31.17M$ -16.24M$ -5.31M
Net Income
$ -80.56M$ -60.39M$ -31.17M$ -16.24M$ -5.31M
Per Share Metrics
Basic EPS
$ -2.10$ -2.74$ -1.42$ -1.26$ -0.41
Diluted EPS
$ -2.10$ -2.74$ -1.42$ -1.26$ -0.41
Weighted Average Shares Outstanding
38.30M 22.08M 21.92M 12.91M 12.91M
Weighted Average Shares Outstanding (Diluted)
38.30M 22.08M 21.92M 12.91M 12.91M
Currency in USD

Acrivon Therapeutics, Inc. Earnings and Revenue History